Lamivudine oral sol.10mg/ml/BOT-240ml gb

General Description
Lamivudine oral solution10mg/ml, bottle pack of 240ml with oral dispensing syringe

Technical Specifications
Each 1ml oral solution contains 10mg of Lamivudine. Pack comes with oral dispensing syringe.

Therapeutic class
Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI)

Standard shelf life
1.5 Years (18 Months)

Other available formulations
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.

Guidelines for use
For more details, please see WHO treatment guidelines www.who.int/hiv/pub/guidelines/en/index.html and WHO Essential Medicines Library www.who.int/emlib/ or your regional/national guidelines.

Details about paediatric dosage schemes can be found at www.who.int/hiv/topics/paediatric/en/index.html

WHO generic tool for assessing paediatric ARV dosing
http://www.who.int/hiv/paediatric/generictool/en/

Indications
Management of HIV infection in combination with at least two other antiretroviral drugs. By mouth (oral) PO.
Prevention of mother to child transmission (PMTCT): In combination with other drugs in the therapy for prevention of maternal-fetal transmission of HIV.

Packaging and storage
Store between 2ºC and 25ºC (36ºF and 77ºF) in a tightly closed container. Do not freeze.
Keep out of reach and sight of children.
Note: Use solution within 1 (one) month after opening.

Dispensing instructions
Dispense in original container. Do not repack
The entire dose, especially for volumes less than 5ml, should be measured and administered accurately using a dose measuring oral syringe or cup. If a cup or spoon is used, rinse it with a small amount of drinking water and administer the rinse to the patient.

Regulatory Status
For latest updates check the list of Prequalified Medicines on the WHO website ‘Prequalification Programme’. apps.who.int/prequal/

For latest updates check the list of USFDA approved and tentatively approved items on the USFDA website. www.fda.gov/default.htm, www.accessdata.fda.gov/Scripts/cder/DrugsatFDA/